Imen Guizani
Tunis, Tunisia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Matrix metalloproteinase 3 and 9 as genetic biomarkers for the occurrence of cardiovascular complications in coronary artery disease: a prospective cohort study.
Journal: Molecular biology reports
Published: March 31, 2022
SARS-CoV-2 and pathological matrix remodeling mediators.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: April 07, 2021
MICA-129 Met/Val polymorphism could be a genetic biomarker for Familial Breast Cancer in the Tunisian population.
Journal: International journal of immunogenetics
Published: November 27, 2019
Matrix metalloproteinase-3 predicts clinical cardiovascular outcomes in patients with coronary artery disease: a 5 years cohort study.
Journal: Molecular biology reports
Published: November 27, 2018
Association of matrix metalloproteinase 3 and endogenous inhibitors with inflammatory markers in mitral valve disease and calcification.
Journal: Molecular biology reports
Published: May 04, 2018
Abnormal Circulating Levels of Metalloproteinase and Their Inhibitor in Hypertensive Patients.
Journal: Clinical laboratory
Published: May 25, 2016
Inflammations mediators and circulating levels of matrix metalloproteinases: Biomarkers of diabetes in Tunisians metabolic syndrome patients.
Journal: Cytokine
Published: February 15, 2016
Metabolic Syndrome, Independent Predictor for Coronary Artery Disease.
Journal: Clinical laboratory
Published: December 09, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026